Structure Therapeutics Inc. GPCR
21.41 USD +1.06 (+5.21%)
At closeNov 10, 2026, 7:00 AM EST
21.25 -0.16 -0.75%
Pre-market · Nov 10, 7:00 AM ET
20.57 Day range 22.13
18.70 52-week range 94.90
- YTD
- -69.22%
- 1 year
- -36.84%
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -176.56M | -158.23M | -102.78M | -52.56M | -37.70M | |
| -141.20M | -122.53M | -89.62M | -51.32M | -40.01M | |
| -2.40 | -2.34 | -2.43 | -16.53 | -16.14 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 799.62M | 169.51M | 129.79M | 26.09M | 105.31M | |
| 1.58B | 903.33M | 482.02M | 97.84M | 111.16M | |
| 67.54M | 38.49M | 29.05M | 13.01M | 8.93M | |
| 6.49M | 3.86M | 5.45M | 260.00K | 621.00K | |
| 1.52B | 864.84M | 452.97M | -115.14M | -64.73M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -222.20M | -116.64M | -79.49M | -46.12M | -32.16M | |
| 89.80M | -358.91M | -268.34M | -62.11M | 17.86M | |
| 762.52M | 515.26M | 451.53M | 29.01M | 103.25M | |
| -3.61M | -1.29M | -2.17M | -155.00K | -1.21M | |
| 630.11M | 39.72M | 103.70M | -79.21M | 88.95M |